Literature DB >> 25267744

Optimal management of clinical stage I nonseminoma: new data for patients to consider.

Ronald de Wit1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25267744     DOI： 10.1200/JCO.2014.56.5747

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

Review 1.  Robotic Primary RPLND for Stage I Testicular Cancer: a Review of Indications and Outcomes.

Authors:  Heather J Chalfin; Wesley Ludwig; Phillip M Pierorazio; Mohamad E Allaf
Journal:  Curr Urol Rep       Date:  2016-05       Impact factor: 3.092

Review 2.  Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration.

Authors:  Thomas A Olson; Matthew J Murray; Carlos Rodriguez-Galindo; James C Nicholson; Deborah F Billmire; Mark D Krailo; Ha M Dang; James F Amatruda; Claire M Thornton; G Suren Arul; Sara J Stoneham; Farzana Pashankar; Daniel Stark; Furqan Shaikh; David M Gershenson; Allan Covens; Jean Hurteau; Sally P Stenning; Darren R Feldman; Peter S Grimison; Robert A Huddart; Christopher Sweeney; Thomas Powles; Luiz Fernando Lopes; Simone dos Santos Agular; Girish Chinnaswamy; Sahar Khaleel; Sherif Abouelnaga; Juliet P Hale; A Lindsay Frazier
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

3.  Primary robotic RLPND for nonseminomatous germ cell testicular cancer: a two-center analysis of intermediate oncologic and safety outcomes.

Authors:  Nicholas R Rocco; Sean P Stroup; Haidar M Abdul-Muhsin; Michael T Marshall; Michael G Santomauro; Matthew S Christman; James O L'Esperance; Erik P Castle
Journal:  World J Urol       Date:  2019-09-09       Impact factor: 4.226

Review 4.  A Review of Outcomes and Technique for the Robotic-Assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer.

Authors:  Zeyad R Schwen; Mohit Gupta; Phillip M Pierorazio
Journal:  Adv Urol       Date:  2018-05-03

5.  The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis.

Authors:  Michael Cullen; Robert Huddart; Johnathan Joffe; Deborah Gardiner; Lauren Maynard; Paul Hutton; Danish Mazhar; Jonathan Shamash; Matthew Wheater; Jeff White; Aicha Goubar; Nuria Porta; Stephanie Witts; Rebecca Lewis; Emma Hall
Journal:  Eur Urol       Date:  2020-01-01       Impact factor: 20.096
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.